SUPERSTRING CAPITAL MANAGEMENT LP
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1931118
NEW YORK, NY
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,206,544
New position
Shares Held
18,867
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#118
of 266 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SUPERSTRING CAPITAL MANAGEMENT LP holds $5,092,548 across 2 Drug Manufacturers - Specialty & Generic names. KNSA ranks #2 (23.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
7,172 | $3,886,004 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
18,867 | $1,206,544 |
All Filings in KNSA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,206,544 | 18,867 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||